- Home
- GOSS vs FMAO Comparison
GOSS vs FMAO Comparison
Compare GOSS & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- FMAO
- Stock Information
- Founded
- GOSS 2015
- FMAO 1897
- Country
- GOSS United States
- FMAO United States
- Employees
- GOSS N/A
- FMAO N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- FMAO Savings Institutions
- Sector
- GOSS Health Care
- FMAO Finance
- Exchange
- GOSS Nasdaq
- FMAO Nasdaq
- Market Cap
- GOSS 347.8M
- FMAO 356.9M
- IPO Year
- GOSS 2019
- FMAO N/A
- Fundamental
- Price
- GOSS $2.47
- FMAO $26.13
- Analyst Decision
- GOSS Strong Buy
- FMAO
- Analyst Count
- GOSS 4
- FMAO 0
- Target Price
- GOSS $8.50
- FMAO N/A
- AVG Volume (30 Days)
- GOSS 3.1M
- FMAO 21.8K
- Earning Date
- GOSS 08-05-2025
- FMAO 10-29-2025
- Dividend Yield
- GOSS N/A
- FMAO 3.34%
- EPS Growth
- GOSS N/A
- FMAO 38.39
- EPS
- GOSS N/A
- FMAO 2.16
- Revenue
- GOSS $40,237,000.00
- FMAO $108,632,000.00
- Revenue This Year
- GOSS N/A
- FMAO $1.60
- Revenue Next Year
- GOSS $30.65
- FMAO $13.77
- P/E Ratio
- GOSS N/A
- FMAO $12.26
- Revenue Growth
- GOSS N/A
- FMAO 13.86
- 52 Week Low
- GOSS $0.66
- FMAO $20.88
- 52 Week High
- GOSS $2.65
- FMAO $34.15
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- FMAO 58.09
- Support Level
- GOSS $2.38
- FMAO $24.60
- Resistance Level
- GOSS $2.65
- FMAO $27.01
- Average True Range (ATR)
- GOSS 0.15
- FMAO 0.81
- MACD
- GOSS 0.03
- FMAO 0.23
- Stochastic Oscillator
- GOSS 76.67
- FMAO 89.44
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.